Building a Sustainable Ecosystem for Patient-Centered Philanthropy in Medical Research

Philanthropy in medical research brings capital, patients, and urgency to the table, but is often limited by an inability to align or scale. Foundations run parallel diligence on the same opportunities, coordination costs more than acting alone, and the infrastructure that would let funders syndicate high-potential research projects largely doesn't exist. What gets lost in that fragmentation isn't just efficiency. Philanthropy, often led by patients, families, and advocates who have lived the urgency of a disease firsthand, brings something institutional capital alone cannot—direct knowledge of what matters most to the people research is meant to serve and an impatience with timelines that treat incremental progress as acceptable. This panel will examine what it would take, in Asia-Pacific and globally, for philanthropy's capital, conviction, and patient-centered urgency to function as a real market rather than as a series of solo bets.